来自官方财务报表的收入、利润与现金流历史。
Cigna Group 及其子公司在美国提供保险及相关产品和服务。它通过两个部门运营：Evernorth Health Services 和 Cigna Healthcare。 Evernorth Health Services部门包括药房福利服务以及专科和护理服务，提供药房福利管理、药物索赔裁决、零售药房网络管理、福利设计咨询、药物使用审查、药物处方管理、药房福利、送货上门药房、专科药房、专科药品分销和针对全人健康结果的临床计划。 Cigna Healthcare 部门包括美国医疗保健和国际健康部门，提供全面的医疗和协调解决方案，例如雇主医疗计划、个人和家庭计划、行为健康、消费者健康参与、牙科、药房管理、止损保险、全球医疗保健和本地医疗保健解决方案，以及为流动个人和跨国组织员工提供医疗保健福利。该公司提供其他业务，包括企业人寿保险、再保险以及某些径流和非战略业务。公司通过经纪人和顾问分销其产品和服务；直接向雇主、工会和其他团体或个人；以及私人和公共交流。该公司前身为 Cigna Corporation，于 2023 年 2 月更名为 The Cigna Group。该公司成立于 1792 年，总部位于康涅狄格州布卢姆菲尔德。
机器翻译
| 利润表 | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 | 2010-12-31 | 2009-12-31 | 2008-12-31 | 2007-12-31 | 2006-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 总收入 | $282.4B | $275.0B | $247.1B | $195.3B | $180.5B | $174.1B | $160.4B | $153.6B | $48.6B | $41.8B | $39.8B | $37.9B | $34.9B | $32.4B | $29.1B | $21.6B | $21.1B | $18.4B | $19.1B | $17.6B | $16.5B |
| 毛利 | $32.9B | $26.0B | $26.0B | $25.2B | $23.5B | $23.0B | $24.2B | $25.1B | $16.3B | $14.1B | $13.0B | $12.5B | $11.7B | $32.4B | $29.1B | $21.6B | $21.1B | $18.4B | $19.1B | $17.6B | $16.5B |
| 毛利率% | 11.7% | 9.4% | 10.5% | 12.9% | 13.0% | 13.2% | 15.1% | 16.3% | 33.6% | 33.7% | 32.7% | 32.9% | 33.4% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| 营业利润（EBIT） | $9.8B | $9.1B | $9.4B | $8.5B | $8.4B | $7.9B | $8.2B | $8.1B | $4.2B | $3.9B | $3.1B | $12.4B | $11.6B | $32.4B | $2.9B | $1.9B | $1.8B | $1.9B | $382M | $1.6B | $1.7B |
| 营业利润率% | 3.5% | 3.3% | 3.8% | 4.4% | 4.7% | 4.6% | 5.1% | 5.3% | 8.6% | 9.4% | 7.8% | 32.6% | 33.2% | 100.0% | 9.9% | 8.7% | 8.6% | 10.3% | 2.0% | 9.2% | 10.5% |
| 净利 | $6.4B | $6.0B | $3.4B | $5.2B | $6.7B | $5.4B | $8.5B | $5.1B | $2.6B | $2.2B | $1.9B | $2.1B | $2.1B | $1.5B | $1.6B | $1.3B | $1.3B | $1.3B | $292M | $1.1B | $1.2B |
| 净利润率 % | 2.3% | 2.2% | 1.4% | 2.6% | 3.7% | 3.1% | 5.3% | 3.3% | 5.4% | 5.3% | 4.7% | 5.5% | 6.0% | 4.6% | 5.6% | 5.8% | 6.1% | 7.1% | 1.5% | 6.3% | 7.0% |
| EBITDA | $11.8B | $11.6B | $11.4B | $10.8B | $10.4B | $10.0B | $10.4B | $11.6B | $5.2B | $4.4B | $3.5B | $3.8B | $3.6B | $597M | $560M | $2.5B | $2.3B | $2.3B | $351M | $1.8B | $1.9B |
| 每股收益（EPS） | $24.15 | $22.40 | $12.12 | $17.39 | $21.41 | $15.75 | $22.96 | $13.44 | $10.69 | $9.17 | $7.19 | $8.04 | $7.83 | $5.18 | $5.61 | $4.59 | $4.65 | $4.73 | $1.05 | $3.94 | $3.43 |
| 已发行股数 (M) | 264M | 266M | 283M | 297M | 313M | 341M | 368M | 380M | 247M | 244M | 260M | 261M | 269M | 285M | 290M | 274M | 275M | 275M | 279M | 283M | 337M |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 CI 交互式查看器。 /companies/us/CI
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms